Table 1.

BDV seroprevalence among human patients by ECLIA with recombinant p40 and p24 proteins

Patient diagnosisMean age + SD% Males/% femalesNo. of positive sera/total no. (%)a
Schizophrenia49.3 + 12.349/5126/845 (3.08)
Mood disorders55.6 + 14.039/619/251 (3.59)
Alcohol addiction51.3 + 6.788/121/42 (2.38)
Mental retardation38.6 + 13.460/400/25 (0)
Alzheimer’s disease82.9 + 8.236/641/89 (1.12)
Vascular dementia78.5 + 8.549/510/46 (0)
Other psychiatric diseases57.0 + 17.248/520/164 (0)
 Subtotal2/366 (0.55)
Neurological diseases37.2 + 16.164/360/114 (0)
 Multiple sclerosis0/67 (0)
 Encephalitis0/33 (0)
 Degenerative diseases0/14 (0)
Epilepsy43.9 + 13.756/443/214 (1.40)
Chronic fatigue syndrome32.0 + 9.860/400/75 (0)
HIV infection (including AIDS)31.9 + 13.497/21/85 (1.18)
Autoimmune diseases47.2 + 17.34/960/50 (0)
Leprosy67.2 + 10.453/470/17 (0)
Multitransfused patients50.6 + 18.652/483/66 (4.55)
Ocular diseases50.1 + 19.142/5819/1,393 (1.36)
Blood donors35.1 + 13.169/3110/917 (1.09)
  • a Statistical analysis data are as follows: schizophrenia versus other psychiatric diseases (χ2 = 6.16; P, >0.01 and <0.025), schizophrenia versus blood donors (χ2 = 8.67; P < 0.005), schizophrenia versus ocular diseases (χ2 = 7.82; P, >0.01 and <0.01), mood disorders versus other psychiatric diseases (χ2 = 6.21; P, >0.025 and <0.01), mood disorders versus donors (χ2 = 7.67; P, >0.01 and <0.005), mood disorders versus ocular diseases (χ2 = 6.27; P, >0.025 and <0.01), and multitransfused patients versus donors (χ2 = 3.30; P, not significant).